Kathleen Melbourne
About
In The Last Decade
Kathleen Melbourne
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Emergency Medicine 1.1k
- Infectious Diseases 898
- Virology 543
- Orthopedics and Sports Medicine 216
- Epidemiology 180
Countries citing papers authored by Kathleen Melbourne
This map shows the geographic impact of Kathleen Melbourne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Melbourne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Melbourne more than expected).
Fields of papers citing papers by Kathleen Melbourne
This network shows the impact of papers produced by Kathleen Melbourne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Melbourne. The network helps show where Kathleen Melbourne may publish in the future.
Co-authorship network of co-authors of Kathleen Melbourne
This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Melbourne. A scholar is included among the top collaborators of Kathleen Melbourne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Melbourne. Kathleen Melbourne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s | 1 |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 5 | |
| 8 | 30 | |
| 9 | 96 | |
| 10 | Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine | 1 |
| 11 | 8 | |
| 12 | 14 | |
| 13 | 29 | |
| 14 | 52 | |
| 15 | 37 | |
| 16 | 78 | |
| 17 | Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 breakdown → | 381 |
| 18 | 107 | |
| 19 | 22 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.